Gordon Marilyn B MD is categorized under Internal Medicine Practitioners in North Falmouth, MA and active since 2001.
Gordon Marilyn B MD was established in 2001, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Marilyn Gordon at the company’s single location by writing to 107 County Road # A, North Falmouth, Massachusetts MA 02556 or by phoning (508) 564-5522. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Gordon Marilyn B MD |
| Contact Person: | Marilyn Gordon |
| Address: | 107 County Road # A, North Falmouth, Massachusetts 02556 |
| Phone Number: | (508) 564-5522 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Practitioners |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Gordon Marilyn B MD was started in 2001 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Marilyn Gordon for inquiries that concern Gordon Marilyn B MD by calling the company number (508) 564-5522, as your correspondence is most welcome. Additionally, the physical location of the single location of Gordon Marilyn B MD can be found at the coordinates 41.64904,-70.616984 as well as the street address 107 County Road # A in North Falmouth, Massachusetts 02556.
For its online presence, you may visit Gordon Marilyn B MD’s website at and engage with its social media outlets through on Twitter and on Facebook.